John Cullity

Président chez HaemaLogiX Pty Ltd. Fortune : 4 M $ au 30/09/2026

Profil

John Cullity is currently the Chairman at HaemaLogiX Pty Ltd. He is also a Director at Theraly Fibrosis, Inc. and a Managing Director at Biosynergy Partners LLC.
Additionally, he is a Member at The Royal College of Physicians.
In his former positions, Dr. Cullity served as a Director of Health Economics at Merk Sharp & Dohme (Holdings) Pty Ltd. and Sanofi-Aventis Healthcare Pty Ltd. He was also a Non-Executive Director at Race Oncology Ltd. from 2018 to 2023 and a Director at Ceramedix Holdings LLC from 2015 to 2020.
Furthermore, he held the position of Senior Member-Business Development at Sanofi-Synthelabo, Inc. and worked as a Principal at Torreya Partners LLC from 2010 to 2017.
Dr. Cullity obtained a graduate degree from the London School of Economics & Political Science.
He also holds an undergraduate degree from The University of Western Australia and an MBA from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
RACURA ONCOLOGY LTD 1,37 %	08/08/2025	2 694 642 ( 1,37 % )	4 M $	30/09/2026

Postes actifs de John Cullity

Sociétés	Poste	Début
Biosynergy Partners LLC	Corporate Officer/Principal	01/09/2013
Theraly Fibrosis, Inc.	Directeur/Membre du Conseil	01/09/2016
HaemaLogiX Pty Ltd.	Président	-
The Royal College of Physicians	Corporate Officer/Principal	-

Anciens postes connus de John Cullity

Sociétés	Poste	Fin
RACURA ONCOLOGY LTD	Président	20/04/2023
Ceramedix Holdings LLC	Directeur/Membre du Conseil	01/03/2020
Torreya Partners LLC	Corporate Officer/Principal	01/01/2017
Sanofi-Aventis Healthcare Pty Ltd.	Corporate Officer/Principal	-
Merk Sharp & Dohme (Holdings) Pty Ltd.	Corporate Officer/Principal	-